Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or... – Inactivation or attenuation; producing viral subunits
Patent
1997-10-20
2000-03-28
Brusca, John S.
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
Inactivation or attenuation; producing viral subunits
435 6, 435 9131, 4353201, 435325, 435366, 435363, 435375, 536 231, 536 232, 536 241, 536 245, C07H 2104, C12N 1585, C12N 1563
Patent
active
06043077&
ABSTRACT:
This invention provides ribozymes useful to treat or prevent Hepatitis C Virus ("HCV") infection or disease in an organism or subject, as well as methods of treating an HCV infection or disease. Reagents such as vectors, host cells, DNA molecules coding for these ribozymes useful in methods of treatment and prevention of HCV infection or disease are also provided.
REFERENCES:
patent: 5254678 (1993-10-01), Haseloff et al.
patent: 5527895 (1996-06-01), Hampel et al.
patent: 5610054 (1997-03-01), Draper
Sakamoto et al., "Inhibition Of Hepatitis C Virus-Directed Translation By Hammered Ribozymes In-Vitro," Hepatology 22(4, Part 2):p. 330A, Abstract No. 896, 1995.
Stull and Szoka, Jr., "Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects," Pharmaceutical Research 12(4):465-483, 1995.
Welch et al., "A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection," Gene Therapy 3:994-1001, 1996.
Anderson et al., "Mutagenesis of the hairpin ribozyme," Nucleic Acids Research 22(6):1096-1100, 1994.
Bhandari and Wright, "Hepatitis C: An Overview," Annu. Rev. Med. 46:309-317, 1995.
Blum, Hubert E., "Variants of Hepatitis B, C and D Viruses: Molecular Biology and Clinical Significance," Digestion 56:85-95, 1995.
Carreno and Quiroga, "Biologic response modifiers in chronic hepatitis C," Journal of Hepatology 22(Suppl. 1):122-126, 1995.
Davis et al., "Therapy For Chronic Hepatitis C," Viral Hepatitis 23(3):603-613, 1994.
Fried and Hoofnagle, "Therapy of Hepatitis C," Seminars in Liver Disease 15(1):82-91, 1995.
Gitnick, G., "Hepatitis C in 1994," Scan J. Gastroenterol 30(Suppl. 208):147-8, 1995.
Hirschman, Shalom Z., "Current Therapeutic Approaches to Viral Hepatitis," Clinical Infectious Diseases 20:741-6, 1995.
Iwarson et al., "Hepatitis C: Natural History of a Unique Infection," Clinical Infectious Diseases 20:1361-70, 1995.
Marcellin et al., "Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction," Journal of Hepatology 22:364-369, 1995.
Nagayama et al., "Exacerbation of Thyroid Autoimmunity by Interferon .alpha. Treatment in Patients with Chronic Viral Hepatitis: Our Studies and Review of the Literature," Endocrine Journal 41(5):565-572, 1994.
Nesbitt and Goodchild, "Further Studies on the Use of Oligonucleotides Facilitators to Increase Ribozyme Turnover," Antisene Research and Development 4:243-249, 1994.
Olynyk and Bacon, "Hepatitis C. Recent advances in understanding and management," Postgraduate Medicine 98(1):79-81, 86-87, 91-92, 94, 1995.
Ramos-Soriano and Schwartz, "Recent Advances In The Hepatitides," Pediatric Gastroenterology, Part I 23(4):753-767, 1994.
Rubin et al., "Chronic Hepatitis C. Advances in Diagnostic Testing and Therapy," Arch Intern Med. 154:387-392, 1994.
Scotiniotis et al., "Hepatitis C: Diagnosis and Treatment," JGIM 10:273-282, 1995.
Trepo et al., "Interferon therapy for hepatitis C," Antiviral Research 24:155-163, 1994.
Wong and Heathcote, "The Role Of Interferon In The Treatment Of Viral Hepatitis," Pharmac. Ther. 63:177-186, 1994.
Stull et al. Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects. Pharmaceutical Research vol. 12(4): 465-483, 1995.
Branch A. A Good Antisense Molecule is Hard to Find. TIBS vol. 23:45-50, Feb. 1998.
Barber Jack R.
Tritz Richard
Welch Peter J.
Yei SoonPin
Yu Mang
Brusca John S.
Immusol Inc.
McGarry Sean
LandOfFree
Hepatitis C virus ribozymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus ribozymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus ribozymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325221